Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-10
2006-10-10
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S363000, C548S136000
Reexamination Certificate
active
07119099
ABSTRACT:
A compound of formula (I) or its enantiomers or diastereoisomers thereof:wherein: A,; X, W, R1, Y; R3; and R4are as defined herein.The compounds of the invention may be used as inhibitors of the papilloma virus E1-E2-DNA complex. The invention further provides a method of treating or preventing human papilloma virus infection.
REFERENCES:
Shah, et al; “Papillomaviruses”, Fields Virology, 3d ed, Ch. 66, 2077-2109, 1996.
Beutner, et al; “Therapeutic Approaches to Genital Warts”; Am. J. Med., 1997, 102(5A), 28-37.
Hughes, et al; “E1 Protein of Human Papillomavirus is a DNA Helicase/ATPase”; Nucleic Acids Res., 1993, vol. 21, No. 25, 5817-5823.
Kuo, et al; “Cell-free Replication of the Human Papillomavirus DNA with Homologous Viral E1 and E2 Proteins and Human Cell Extracts”, J. Biol. Chem., 1994, vol. 269, No. 39, 24058-24065.
Seo, et al; “Bovine papilloma virus (BPV)-encoded E1 protein contains multiple activities required for BPV DNA replication”; Proc. natl. Acad. Sci USA; 1993: vol. 90. 702-706.
Yang, et al; “The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA helicase”; Proc. Natl. Acad. Sci. USA; 1993; vol. 90, 5086-5090.
MacPherson, et al; “The Bovine Papilloma Virus E1 Protein Has ATPase Activity Essential to Viral DNA Replication and Efficient Transformation in Cells”; Virology, 1994, 204, 403-408.
Mohr, et al; “Targeting the E1 Replication Protein to the Papillomavirus Origin of Replication by Complex Formation with the E2 Transactivator”; Science, 1990, 250; 1694-1699.
Seo, et al; “Bovine papilloma virus (BPV)-encoded E2 protein enhances binding of E1 protein to the BPV replication origin”; Proc. Natl. Acad. Sci. USA, 1993; vol. 90, 2865-2869.
Liu, et al; “The Functions of Human Papillomavirus Type 11 E1, E2, and E2C Proteins in Cell-free DNA Replication”; J. Biol. Chem., 1995, 270(45), 27283-27291.
Buckle, et al; “Antiallergic Activity of 2-Nitroindan-1,3-diones”; J. Med. Chem., 1973, vol. 16, No. 12, 1334-1339.
Koskinen, et al; “Diazo Transfer Reactions under Mildly Basic Conditions”; J. Chem. Soc. Chem. Commun.; 1990, 652-653.
Villeneuve, et al; “A Rapid, Mild and Acid-Free Procedure for the Preparation of Acyl Chlorides Including Formyl Chloride”; Tetrahedron Letters, 1997, vol. 38, No. 37, 6489-6492.
Krysin, et al; “1,3-Dipolar Cycloaddition of 2-Benzylideneindan-,3-Dione-alpha-Oxide to Olefins”; Khimiya Geterotsiklicheskikh Soedinenii, 1987, 11, 1463-1466.
Reddy, et al; “Lewis Acid and Hexamethyldisilazane-Promoted Efficient Synthesis of N-Alkyl- and N-Arylimide Derivatives”; J. Org. Chem. 1997, 62, 2652-2654.
Chiang, et al; “Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins”; Proc. Natl. Acad. Sci. USA, 1992, vol. 89, 5799-5803.
McKay; “Binding of a Simian Virus 40 T Antigen-related Protein to DNA”; J. Mol. Biol. 1981, 145, 471-488.
Goudreau Nathalie
O'Meara Jeffrey
Ogilvie William W.
White Peter
Yoakim Christiane
Boehringer Ingelheim (Canada) Ltd.
Datlow Philip I.
Devlin Mary Ellen M.
Morris Michael P.
Saeed Kamal A.
LandOfFree
Inhibitors of papilloma virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of papilloma virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of papilloma virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3682939